Skip to content

Study to Evaluate the Efficacy and Safety of Sevikar HCT® in Elderly Patients with Hypertension

A Pooled Data Analysis Study to Evaluate the Efficacy and Safety of Sevikar HCT® in Elderly Patients with Hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0010343
Enrollment
16646
Registered
2025-03-27
Start date
2024-04-17
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who meet the inclusion/exclusion criteria of the previous observational studies

Exclusion criteria

Exclusion criteria: 1) Patients with missing values for systolic blood pressure and diastolic blood pressure at baseline 2) Patients with controlled blood pressure at baseline (systolic blood pressure <140 mmHg and diastolic blood pressure <90 mmHg at baseline).

Design outcomes

Primary

MeasureTime frame
Changes from baseline in systolic blood pressure, diastolic blood pressure, and pulse pressure in elderly patients

Secondary

MeasureTime frame
Changes from baseline in systolic blood pressure, diastolic blood pressure, and pulse pressure by age;Changes from baseline in systolic blood pressure, diastolic blood pressure, and pulse pressure by isolated systolic hypertension classification;Changes from baseline in systolic blood pressure, diastolic blood pressure, and pulse pressure by cardiovascular disease risk factor;Occurrence of hypotensive adverse events related to Sevikar HCT® Tab. by age and by isolated systolic hypertension classification

Countries

Korea, Republic of

Contacts

Public ContactDae-Hee Kim

Asan Medical Center

daehee74@amc.seoul.kr+82-2-3010-3151

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Apr 1, 2026